ZURICH, May 21 (Reuters) - Addex Pharmaceuticals raised 137 million Swiss francs ($111.3 million) in its initial public offering on Monday to help bring its small molecule drugs to market.
ZURICH, May 21 (Reuters) - Addex Pharmaceuticals raised 137 million Swiss francs ($111.3 million) in its initial public offering on Monday to help bring its small molecule drugs to market.